Akihiro Ko joined Elixirgen, LLC in 2015 and worked as Chief Operating Officer. Through his management efforts, he optimized the company’s business development and operations. With the establishment of Elixirgen Scientific, LLC, he assumed the position of President in August 2016. He has been responsible for business operations, marketing, and. d business development at Elixirgen Scientific. In 2017, he joined Elixirgen Therapeutics as Chief Executive Officer. He earned a Bachelor of Science degree from University of Virginia, where he cultivated his interest in stem cell biology and epigenetics through his research involving bivalent domains in cancer stem cells.
